A formulary restriction policy in a Medicare population was associated with lower celecoxib utilization; however, higher gastrointestinal- and arthritis-related medical costs were observed.
Amy T. Ball, PharmD
Advertisement
Articles by Amy T. Ball, PharmD
Advertisement
Latest Updated Articles
- Impact of Celecoxib Restrictions in Medicare Beneficiaries With Arthritis
Published: July 14th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
FDA Expands Sotatercept Indication for PAH
4
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
5
